デフォルト表紙
市場調査レポート
商品コード
1771031

獣医CROおよびCDMO市場- 世界の産業規模、シェア、動向、機会、予測：動物別、サービス別、用途別、地域別セグメント、競合、2020年～2030年

Veterinary CRO And CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal, By Service, By Application, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 184 Pages
納期
2～3営業日
カスタマイズ可能
獣医CROおよびCDMO市場- 世界の産業規模、シェア、動向、機会、予測：動物別、サービス別、用途別、地域別セグメント、競合、2020年～2030年
出版日: 2025年07月14日
発行: TechSci Research
ページ情報: 英文 184 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

獣医CROおよびCDMOの世界市場は、2024年に57億8,000万米ドルと評価され、2030年には96億5,000万米ドルに達し、CAGR 8.90％で成長すると予測されています。

この成長には、製薬会社やバイオテクノロジー企業が研究開発・製造のアウトソーシングを進め、業務負担を軽減し、スケジュールを短縮する傾向が強まっていることが背景にあります。動物用治療薬、ワクチン、生物製剤、特にコンパニオンアニマルや家畜用の需要の増加は、コスト効率とコンプライアンスに優れた受託機関の必要性を高めています。CROは臨床と薬事機能をサポートし、CDMOは製剤から商業生産まで全領域のサービスを提供します。さらに、人獣共通感染症や感染症の脅威の急増は、動物衛生分野における研究開発投資を強化し、専門的なアウトソーシング・パートナーの市場を後押ししています。市場に影響を与える主な動向は、CRO、CDMO、動物用医薬品開発企業間の戦略的提携や買収の増加です。これは、世界のプレゼンスを拡大し、デジタルツールやバイオマーカー研究のような技術対応プラットフォームを臨床研究に統合する必要性が背景にあります。

市場概要
予測期間 2026-2030
市場規模：2024年 57億8,000万米ドル
市場規模：2030年 96億5,000万米ドル
CAGR：2025年～2030年 8.90%
急成長セグメント 医療機器
最大市場 北米

市場促進要因

コンパニオンアニマルの飼育増加とヘルスケア支出の増加

主な市場課題

熟練した獣医学研究の専門家の限られた入手可能性

主要市場動向

生物製剤および先進的動物用治療薬に対する需要の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の獣医CROおよびCDMO市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 動物別（コンパニオンアニマル、家畜）
    • サービス別（発見、開発、製造、パッケージングとラベリング、市場承認と上市後）
    • 用途別（医薬品、生物製剤、医療機器、その他）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の獣医CROおよびCDMO市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の獣医CROおよびCDMO市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の獣医CROおよびCDMO市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の獣医CROおよびCDMO市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの獣医CROおよびCDMO市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet（Pty）Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 29982

The Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by the increasing tendency of pharmaceutical and biotechnology firms to outsource research, development, and manufacturing to reduce operational loads and accelerate timelines. Rising demand for veterinary therapeutics, vaccines, and biologics-particularly for companion animals and livestock-has amplified the need for cost-efficient and compliant contract organizations. CROs support clinical and regulatory functions, while CDMOs offer full-spectrum services from formulation to commercial manufacturing. Additionally, the surge in zoonotic diseases and infectious threats has intensified R&D investments in animal health, boosting the market for specialized outsourcing partners. A major trend influencing the market is the uptick in strategic collaborations and acquisitions among CROs, CDMOs, and veterinary drug developers, driven by the need to broaden global presence and integrate tech-enabled platforms like digital tools and biomarker studies in clinical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.78 Billion
Market Size 2030USD 9.65 Billion
CAGR 2025-20308.90%
Fastest Growing SegmentMedical Devices
Largest MarketNorth America

Key Market Drivers

Increase in Companion Animal Ownership and Healthcare Spending

The growing number of companion animals and rising expenditure on their healthcare are pivotal factors driving the Veterinary CRO and CDMO market. Increasingly, pets are being viewed as family members, reshaping consumer spending patterns. According to the 2024 Pet Ownership Survey by the American Veterinary Medical Association, 45.5% of U.S. households own dogs and 32.1% own cats-amounting to nearly 90 million dogs and 74 million cats. Annual veterinary spending averages USD 580 per dog and USD 433 per cat. This surge in pet population and associated healthcare costs has led pharmaceutical and biotech companies to expand their veterinary pipelines, thereby increasing the demand for outsourced R&D and manufacturing services.

Key Market Challenges

Limited Availability of Skilled Veterinary Research Professionals

A significant hurdle in the Global Veterinary CRO and CDMO Market is the shortage of skilled veterinary research professionals. Veterinary clinical and preclinical studies require specialized knowledge across diverse species, drug mechanisms, behavioral patterns, and compliance standards. Unlike human trials, veterinary research spans a wide array of animals-companion pets, livestock, equines, and exotic species-each with unique biological needs. This diversity demands expertise in veterinary science, clinical trial methodologies, ethical considerations, and animal care protocols. However, a global shortfall of such multidisciplinary professionals hampers the scalability, timeline adherence, and quality maintenance capabilities of CROs and CDMOs.

Key Market Trends

Increased Demand for Biologics and Advanced Veterinary Therapeutics

The demand for biologics and next-generation veterinary therapeutics is significantly shaping the Veterinary CRO and CDMO market. As animal health issues become more complex, there's a growing preference for high-efficacy biologics like monoclonal antibodies, recombinant proteins, and DNA-based vaccines over traditional small-molecule drugs. These innovative solutions are being developed to address serious conditions such as cancer, autoimmune diseases, and chronic infections in both companion and farm animals. This trend is expanding the need for specialized services from CROs and CDMOs, including immunogenicity evaluations, bioanalytical testing, and biologics manufacturing under high-containment protocols. The advanced infrastructure and analytical capabilities required for biologics are fueling the reliance on expert contract organizations.

Key Market Players

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet (Pty) Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

Report Scope:

In this report, the Global Veterinary CRO And CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO And CDMO Market, By Animal:

  • Companion Animals
  • Livestock Animals

Veterinary CRO And CDMO Market, By Service:

  • Discovery
  • Development
  • Manufacturing
  • Packaging & Labeling
  • Market Approval & Post Marketing

Veterinary CRO And CDMO Market, By Application:

  • Pharmaceuticals
  • Biologics
  • Medical Devices
  • Others

Veterinary CRO And CDMO Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary CRO And CDMO Market.

Available Customizations:

Global Veterinary CRO And CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary CRO And CDMO Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal (Companion Animals, Livestock Animals)
    • 5.2.2. By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing)
    • 5.2.3. By Application (Pharmaceuticals, Biologics, Medical Devices, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Veterinary CRO And CDMO Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal
    • 6.2.2. By Service
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary CRO And CDMO Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Application
    • 6.3.2. Mexico Veterinary CRO And CDMO Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Application
    • 6.3.3. Canada Veterinary CRO And CDMO Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Application

7. Europe Veterinary CRO And CDMO Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal
    • 7.2.2. By Service
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary CRO And CDMO Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Veterinary CRO And CDMO Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Veterinary CRO And CDMO Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Veterinary CRO And CDMO Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Veterinary CRO And CDMO Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Application

8. Asia-Pacific Veterinary CRO And CDMO Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal
    • 8.2.2. By Service
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary CRO And CDMO Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Application
    • 8.3.2. India Veterinary CRO And CDMO Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Application
    • 8.3.3. South Korea Veterinary CRO And CDMO Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Application
    • 8.3.4. Japan Veterinary CRO And CDMO Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Veterinary CRO And CDMO Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Application

9. South America Veterinary CRO And CDMO Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal
    • 9.2.2. By Service
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary CRO And CDMO Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Veterinary CRO And CDMO Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Veterinary CRO And CDMO Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Application

10. Middle East and Africa Veterinary CRO And CDMO Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal
    • 10.2.2. By Service
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary CRO And CDMO Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Veterinary CRO And CDMO Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Veterinary CRO And CDMO Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fortrea Holdings Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Charles River Laboratories International, Inc.
  • 15.3. Clinvet (Pty) Ltd.
  • 15.4. KLIFOVET GmbH
  • 15.5. Veterinary Research Management, Inc.
  • 15.6. VETSPIN SRL
  • 15.7. Inotiv, Inc.
  • 15.8. IDEXX Laboratories, Inc.
  • 15.9. Vetio Animal Health
  • 15.10. TriRx Pharmaceutical Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer